Oncology market to 2023 robust growth driven by rising prevalence and increased uptake of immune checkpoint inhibitors

1
Oncology Market to 2023 - Robust Growth Driven by
Rising Prevalence and Increased Uptake of Immune
Checkpoint Inhibitors

• Published On 14 Jul

E-mail help_at_grandresearchstore.com
2
Report Description
In 2012, there were 32.6 million people living
with any type of cancer within five years of
diagnosis. These are generally incurable once
they progress to the stage where they are
unresectable. Chemotherapy compounds are a
mainstay treatment for cancers of all types, at
various disease stages. In a typical course of
therapy for cancer, multiple chemotherapy
compounds are administered sequentially in
combination regimens, as an adjunct to surgery
and radiation therapy. Chemotherapy drugs are
cytotoxic to dividing cells, meaning that they
act on both healthy and malignant tissues and are
fairly toxic. However, they exert more damage
on malignant tissue than healthy tissue due to
the rapid cell cycle of cancer cells. The key
cancer indications of this report are breast,
colorectal, lung, and prostate and hematological
cancers.
E-mail help_at_grandresearchstore.com
3
Table of content
1 Table of Contents1 Table of Contents 51.1 List
of Tables 71.2 List of Figures 7 2 Introduction
 102.1 Therapy Area Introduction 102.2 Symptoms
112.3 Diagnosis 12 3 Key Marketed Products
313.1 Overview 313.2 MabThera/Rituxan rituximab
32
E-mail help_at_grandresearchstore.com
4
Oncology Market Value
xx
xx
xx
xx
CAGR 8.7 (2018 - 2023)
xx
xx
xx
xx
E-mail help_at_grandresearchstore.com
5
Get in touch
Get in touch
Click here to know more about report
Follow us
1 [phone] (International)
91 8087042414 (Asia)
www.grandresearchstore.com
help_at_grandresearchstore.com